Latest Als News

Algorae Pharmaceuticals reported a 62% reduction in net loss for FY2025, driven by R&D tax credits and cost efficiencies, while making significant strides in its AI drug discovery platform and therapeutic candidates.

Control Bionics Limited has announced a $2.06 million non-renounceable rights issue to fund the commercial expansion of its NeuroStrip device and bolster NeuroNode operations. The capital raise is underwritten to approximately $1.15 million by major shareholders and strategic partners.

Invictus Energy has forged a landmark partnership with Al Mansour Holdings, securing a strategic 19.9% stake and up to US$500 million in funding to advance its Cabora Bassa Project and expand into African upstream oil and gas markets.

WAM Active Limited reported a robust 26.4% increase in its investment portfolio for FY2025, significantly outperforming key benchmarks, while maintaining its fully franked dividend at 6.0 cents per share.

Neurizon Therapeutics reported a $16.6 million loss for FY2025 amid significant progress in its lead neurodegenerative therapy NUZ-001, including regulatory milestones and a global licensing deal. The company is poised to enter a pivotal ALS clinical trial pending FDA clearance.

Solis Minerals has reported significant visual copper and molybdenum mineralisation over approximately 350 metres in its first diamond drill hole at the Ilo Este project in Peru, with assay results due in September 2025.

Verity Resources has completed a significant infill drilling program at its Korong deposit, aiming to upgrade its gold resource classification and pave the way for future development studies.

Venus Metals Corporation reports outstanding metallurgical test results from its Bellchambers Gold deposit, confirming high gold recoveries and a straightforward processing route. The findings bolster the project's economic prospects and hint at future cost efficiencies.

Alara Resources has achieved a significant 77% increase in daily copper concentrate production at its Al Wash-hi Majaza mine in Oman, marking a major operational milestone.

West Coast Silver has reported extraordinary high-grade silver and gold intercepts from its maiden diamond drilling program at the Elizabeth Hill Silver Project, highlighting near-surface mineralisation with grades that could reshape project economics.

Resource Minerals International Ltd has acquired a 50% interest in a Saudi Arabian joint venture, gaining access to the highly prospective Shaib Marqan gold and base metals exploration licence. This move positions RMI to leverage Saudi Arabia’s expanding mining sector under Vision 2030 reforms.

Neurizon Therapeutics reports encouraging topline results from its Phase 1 Open-Label Extension study of NUZ-001, demonstrating long-term safety and a significant survival advantage in ALS patients. These findings pave the way for the pivotal HEALEY ALS Platform Trial planned for late 2025.